Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Common Stock Shares Outstanding of 192.30 million shares for the year ending 2025.
- BIOMARIN PHARMACEUTICAL INC showed an increase of +0.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BIOMARIN PHARMACEUTICAL INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: 102.02 million shares | Q3 2010: 102.46 million shares | Q1 2011: 110.87 million shares | Q2 2011: 111.56 million shares | Q3 2011: 114.15 million shares | Q1 2012: 115.68 million shares | Q2 2012: 123.24 million shares | Q3 2012: 123.79 million shares | Q1 2013: 138.87 million shares | Q2 2013: 140.05 million shares | Q3 2013: 142.20 million shares | Q1 2014: 145.74 million shares | Q2 2014: 147.07 million shares | Q3 2014: 147.43 million shares | Q1 2015: 160.28 million shares | Q2 2015: 161.01 million shares | Q3 2015: 161.23 million shares | Q1 2016: 162.24 million shares | Q2 2016: 163.28 million shares | Q3 2016: 171.70 million shares | Q1 2017: 173.30 million shares | Q2 2017: 175.25 million shares | Q3 2017: 175.50 million shares | Q1 2018: 176.65 million shares | Q2 2018: 177.51 million shares | Q3 2018: 177.90 million shares | Q1 2019: 179.03 million shares | Q2 2019: 179.43 million shares | Q3 2019: 179.60 million shares | Q1 2020: 180.76 million shares | Q2 2020: 181.15 million shares | Q3 2020: 181.49 million shares | Q1 2021: 182.67 million shares | Q2 2021: 183.32 million shares | Q3 2021: 183.57 million shares | Q1 2022: 184.90 million shares | Q2 2022: 185.45 million shares | Q3 2022: 185.82 million shares | Q1 2023: 187.60 million shares | Q2 2023: 188.15 million shares | Q3 2023: 188.34 million shares | Q1 2024: 189.78 million shares | Q2 2024: 190.36 million shares | Q3 2024: 190.55 million shares | Q1 2025: 191.76 million shares | Q2 2025: 192.00 million shares | Q3 2025: 192.10 million shares.
- Over the full 17 years of available data (2009 to 2025), BIOMARIN PHARMACEUTICAL INC's Common Stock Shares Outstanding has grown by 90.5%.
- Historical annual values: Fiscal year 2025: 192.30 million shares | Fiscal year 2024: 190.76 million shares | Fiscal year 2023: 188.60 million shares | Fiscal year 2022: 186.25 million shares | Fiscal year 2021: 183.91 million shares | Fiscal year 2020: 181.74 million shares | Fiscal year 2019: 179.84 million shares | Fiscal year 2018: 178.25 million shares | Fiscal year 2017: 175.84 million shares | Fiscal year 2016: 172.65 million shares | Fiscal year 2015: 161.53 million shares | Fiscal year 2014: 149.09 million shares | Fiscal year 2013: 143.46 million shares | Fiscal year 2012: 125.81 million shares | Fiscal year 2011: 114.79 million shares | Fiscal year 2010: 110.63 million shares | Fiscal year 2009: 100.96 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: